# Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-immunogenicity-and-safety-of-the-as04-hpv-16-18-vaccine-in-chinese/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Fengcai Zhu,Shangying Hu,Ying Hong,Yuemei Hu,Xun Zhang,Yiju Zhang,Qin‐Jing Pan,Wen‐Hua Zhang,Fanghui Zhao,Chengfu Zhang,Xiaoping Yang,Jia‐Xi Yu,Jiahong Zhu,Yejiang Zhu,Feng Chen,Qian Zhang,Hong Wang,Changrong Wang,Jun Bi,Shiyin Xue,Lingling Shen,Yanshu Zhang,Yunkun He,Haïwen Tang,Naveen Karkada,P.V. Suryakiran,Dan Bi,Frank Struyf |
| Citations | 57 |
| DOI | 10.1002/cam4.2399 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2399 |
| OpenAlex ID | https://openalex.org/W2961523598 |
| PMID | 31305011 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Dan Bi](https://scholariq.org/researchers/dan-bi/)

## Paper journal

- [Cancer Medicine](https://scholariq.org/journals/cancer-medicine/)

## Paper primary topic

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)

## Paper topics

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.